|
⚲
|
| Keyboard |
| Roger Perlmutter | |
|---|---|
| Firm | |
| Address | c/o Ngm Bio Holdings, Inc 611 Gateway Blvd, Suite 540 South San Francisco, CA 94080 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Eikon Therapeutics Inc | 021-539574 | Executive Officer | 350.7 M of 400.0 M |
||
| NGM Bio Holdings Inc | 021-519045 | Director | 142.0 M of 142.0 M |
||
| Eikon Therapeutics Inc | 021-483121 | Executive Officer | 140.8 M of 535.0 M |
||
| Eikon Therapeutics Inc | 021-428246 | Executive Officer | 517.8 M of 525.0 M |
||
| Eikon Therapeutics Inc | 021-399311 | Executive Officer | 102.5 M of 107.8 M |
||
| Exonics Therapeutics Inc | 021-299113 | Director | 22.0 M of 42.0 M |
||
| Amgen Inc | 021-156628 | Executive Officer | of 2,500.0 M |
||
| Immune Design Corp | 021-145953 | Director | 34.0 M of 34.0 M |
||